Global MicroRNA Profiling for Diagnostic Appraisal of Melanocytic Spitz Tumors

Abstract Background Melanoma skin cancer remains the leading cause of skin cancer related deaths. Spitz lesions represent a subset of melanocytic skin lesions characterized by epitheloid or spindled melanocytes organized in nests. These lesions occupy a spectrum ranging from benign Spitz and atypica...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of surgical research 2016-10, Vol.205 (2), p.350-358
Hauptverfasser: Latchana, Nicholas, MD, MS, Regan, Kelly, BA, Howard, J. Harrison, MD, Aldrink, Jennifer H., MD, Ranalli, Mark A., MD, Peters, Sara B., MD, Zhang, Xiaoli, PhD, Gru, Alejandro, MD, Payne, Philip R.O., PhD, Suarez-Kelly, Lorena P., MD, Carson, William E., MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Background Melanoma skin cancer remains the leading cause of skin cancer related deaths. Spitz lesions represent a subset of melanocytic skin lesions characterized by epitheloid or spindled melanocytes organized in nests. These lesions occupy a spectrum ranging from benign Spitz and atypical Spitz lesions all the way to malignant Spitz tumors. Appropriate management is reliant on accurate diagnostic classification, yet this effort remains challenging utilizing current light microscopic techniques. The discovery of novel biomarkers such as microRNAs (miR) may ultimately be a useful diagnostic adjunct for the evaluation of Spitz lesions. miR expression profiles have been suggested for non-Spitz melanomas but have yet to be ascribed to Spitz lesions. We hypothesized that distinct miR expression profiles would be associated with different lesions along the Spitz spectrum. Materials and Methods RNA extracted from paraffin embedded, formalin fixed tissues of 11 resected skin lesions including benign nevi (n=2), benign Spitz lesions (n=3), atypical Spitz lesions (n=3), and malignant Spitz tumors (n=3) were analyzed by the NanoString platform for simultaneous evaluation of over 800 miRs in each patient sample. Results Benign Spitz lesions had increased expression of miR-21-5p and miR-363-3p compared to benign nevi. Malignant Spitz lesions exhibited over-expression of miR-21-5p, miR-155-5p, and miR-1283 relative to both benign nevi and benign Spitz tumors. Notably, atypical Spitz tumors had increased expression of miR-451a and decreased expression of miR-155-5p expression relative to malignant Spitz lesions. Conversely, atypical Spitz lesions had increased expression of miR-21-5p, miR-34a-5p, miR-451a, miR-1283, and miR-1260a relative to benign Spitz tumors. Conclusions Overall, distinct miR profiles are suggested among Spitz lesions of varying malignant potential with some similarities to non-Spitz melanoma tumors. This work demonstrates the feasibility of this analytic method and forms the basis for further validation studies.
ISSN:0022-4804
1095-8673
DOI:10.1016/j.jss.2016.06.085